A Trial of Fedratinib in Subjects With DIPSS, Intermediate or High-Risk Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis and Previously Treated With Ruxolitinib

Local Institution - 115, New York

Local Institution - 124, New York

Local Institution - 130, Brooklyn

SUNY Upstate Medical University, Syracuse

Local Institution - 106, Pittsburgh

Local Institution - 118, Bethesda

Local Institution - 127, Columbia

Local Institution - 105, Chapel Hill

Local Institution - 114, Durham

Local Institution - 113, Augusta

Local Institution - 126, Miami

Local Institution - 111, Cincinnati

Local Institution - 103, Ann Arbor

Local Institution - 108, Sioux Falls

Local Institution - 121, Park Ridge

Local Institution - 112, Chicago

Local Institution - 109, Chicago

Local Institution - 101, St Louis

Local Institution - 132, Fort Worth

Local Institution - 110, Houston

Local Institution - 120, San Antonio

Local Institution - 117, Aurora

Local Institution - 116, Seattle

Local Institution - 100, Kansas City

Local Institution - 123, Baltimore

Local Institution - 128, Newark

Local Institution - 119, Dallas

Local Institution - 129, Madison

Local Institution - 203, Vancouver

Local Institution - 207, London

Local Institution - 205, Ottawa

Local Institution - 200, Toronto

Local Institution - 201, Montreal

Local Institution - 202, Montreal

Local Institution - 204, Sherbrooke